Insilico Medicine Launches AI-Powered Virtual Aging Cell
Hong Kong, August 14, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has...
Gene Expression
Advertisement
Fannin Advances Ewing Sarcoma Therapy With New Grants
Houston, Texas, August 14, 2026 Fannin Partners, LLC has received new grants from the Congressionally Directed Medical Research Programs...
Insilico and THPharm Expand AI Drug Development Strategy
Seoul, South Korea, August 12, 2026 THPharm is advancing an artificial intelligence-driven indication expansion strategy in partnership with Insilico...
Candel Therapeutics Announces Extended Phase 3 Data Presentation at ASTRO 2026
NEEDHAM, Mass., Aug. 3, 2026 Candel Therapeutics, Inc. announced that new data from its Phase 3 clinical program evaluating...
Design Therapeutics Reports RESTORE-FA Progress and Advances GeneTAC® Pipeline
CARLSBAD, Calif., Aug. 3, 2026 Design Therapeutics, Inc. reported second-quarter 2026 financial results while providing key clinical updates across...
Advertisements
GeneCentric Launches ExpressCT Rewind to Unlock Gene Expression from Liquid Biopsy Data
DURHAM, N.C., July 8, 2026 GeneCentric has announced the launch of ExpressCT Rewind™, a retrospective fragmentomics analysis service designed...
Allarity Therapeutics Secures U.S. Patent for DRP® Platform
TARPON SPRINGS, Fla., June 30, 2026 Allarity Therapeutics, Inc. announced that the U.S. Patent and Trademark Office (USPTO) has...
Advertisement
